A Significant Milestone Towards Aiding Rare Diseases Companies Leverage Cutting-Edge Technology and Consulting Expertise to Elevate Patient Care
CustomerInsights.AI is pleased to announce a global strategic go-to-market partnership with Ambit, a technology-enabled solutions company focused on rare and specialty diseases companies.
By combining ciPARTHENON™’s scalable, ready-to-deploy, Life Sciences-specific data architecture & models, automated workflows, ML & GenAI capabilities and 40+ out-of-the-box apps with Ambit’s consulting expertise and services in rare and specialty diseases, this partnership aims to accelerate the development and deployment of data and analytics solutions.
Abhay Jajoo, CEO of CustomerInsights.AI, said, “Teaming up with Ambit unlocks endless possibilities. Together, through ciPARTHENON™ and its no-code apps, we’ll support the rare and specialty disease markets, efficiently and effectively, driving innovation and meaningful change.”
Rob Sederman, CEO of Ambit, emphasized, “Ambit’s experience in rare and specialty diseases has highlighted the need for novel approaches to data management and commercial operations that are tailored to the unique challenges biopharma companies face in this space. CustomerInsights.AI‘s ciPARTHENON™ platform and apps enable us to bring scalable digital transformation solutions that are fit-for-purpose for our clients and support their commercial success. ”
The CIAI-Ambit partnership underscores their shared commitment to innovation, excellence, and customer satisfaction. With combined strengths and complementary capabilities, the partnership will deliver unparalleled value to help Life Sciences companies navigate the challenges of diagnosis, treatment, and disease management.
Source: PRNewsWire
